Publication: 2884

Publication: 2884

Phase III, randomized, double blind, placebo (P)-controlled trial of sorafenib (S) in desmoid tumor, (DT) (ALLIANCE A091105)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 36 (no. 15_suppl) 11500-11500

Meeting Instance:: ASCO 2018
Year:: 2018
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 2964

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10CA077202, U10CA180820, U10CA180888, U24CA196171

Corr. Author:
Authors:: Mrinal M. Gounder Michelle R. Mahoney Brian Andrew Van Tine Vinod Ravi Steven Attia Hari Anant Deshpande Abha A. Gupta Mohammed M. Milhem Robert Martin Conry Sujana Movva Michael J. Pishvaian Jeffrey Crawford Tarek Sabagh Robert G. Maki William D. Tap Robert A Lefkowitz Narasimhan P Agaram John Joseph Wright Amylou C. Dueck Gary K. Schwartz

Networks:: COLUMBIA, IA018, LAPS-CT018, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-TX035, OH084

Study: Alliance-A091105
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: